Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 15, 2025 • 4:00 AM ET

Date/Time Source News Release
06/04/2025 05:33 PM EDT Business Wire Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05/08/2025 04:05 PM EDT Business Wire Puma Biotechnology Reports First Quarter Financial Results
05/06/2025 05:15 PM EDT Business Wire Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
04/30/2025 06:00 AM EDT GlobeNewswire Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients
04/28/2025 03:03 PM EDT Business Wire Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025
04/24/2025 04:11 PM EDT Business Wire Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results
04/02/2025 05:15 PM EDT Business Wire Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03/26/2025 09:00 AM EDT Business Wire Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025
03/05/2025 06:05 PM EST Business Wire Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03/05/2025 04:11 PM EST Business Wire Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference
Page